- Home
- NTWK vs ATRA Comparison
NTWK vs ATRA Comparison
Compare NTWK & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- ATRA
- Stock Information
- Founded
- NTWK 1997
- ATRA 2012
- Country
- NTWK United States
- ATRA United States
- Employees
- NTWK N/A
- ATRA N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTWK Technology
- ATRA Health Care
- Exchange
- NTWK Nasdaq
- ATRA Nasdaq
- Market Cap
- NTWK 50.8M
- ATRA 67.9M
- IPO Year
- NTWK 1998
- ATRA 2014
- Fundamental
- Price
- NTWK $4.08
- ATRA $10.96
- Analyst Decision
- NTWK
- ATRA Strong Buy
- Analyst Count
- NTWK 0
- ATRA 4
- Target Price
- NTWK N/A
- ATRA $20.00
- AVG Volume (30 Days)
- NTWK 63.3K
- ATRA 65.1K
- Earning Date
- NTWK 09-29-2025
- ATRA 08-15-2025
- Dividend Yield
- NTWK N/A
- ATRA N/A
- EPS Growth
- NTWK N/A
- ATRA N/A
- EPS
- NTWK 0.02
- ATRA N/A
- Revenue
- NTWK $64,127,568.00
- ATRA $199,732,000.00
- Revenue This Year
- NTWK N/A
- ATRA N/A
- Revenue Next Year
- NTWK N/A
- ATRA N/A
- P/E Ratio
- NTWK $201.96
- ATRA N/A
- Revenue Growth
- NTWK 9.18
- ATRA 475.53
- 52 Week Low
- NTWK $2.14
- ATRA $5.01
- 52 Week High
- NTWK $4.60
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NTWK 54.88
- ATRA 54.12
- Support Level
- NTWK $3.97
- ATRA $10.92
- Resistance Level
- NTWK $4.50
- ATRA $11.79
- Average True Range (ATR)
- NTWK 0.28
- ATRA 1.05
- MACD
- NTWK -0.04
- ATRA -0.18
- Stochastic Oscillator
- NTWK 35.80
- ATRA 18.40
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).